advancing muscular dystrophy research

mdcrc logo

University of Washington
Department of Neurology

GLEN BANKS, Ph.D.

MANUSCRIPTS

Banks GB, Gregorevic P, Allen JM, Finn EE, Chamberlain JS (2007). Functional
capacity of dystrophins carrying deletions in the N-terminal actin-binding
domain.
Hum Mol Gen: In Press

PRESENTATIONS

Odom GO, Banks GB, Allen JM, and Chamberlain JS: Functional analysis of
alpha-dystrobrevin-3 in striated muscle with rAAV6 gene transfer.
Presented
at the XIV Annual Meeting of the European Society of Gene Therapy, November
9-12 2006, Athens, Greece.

Banks GB , Judge LM, Gregorevic P, Li S, Doremus C, Meuse L, Finn EE, Allen
JM , Froehner SC and Chamberlain JS: Microdystrophin expression in mouse
models of Duchenne Muscular Dystrophy reveals novel roles for full-length
dystrophin at the myotendinous junction.
10th annual meeting of the
Australasian Gene Therapy Society, April 18-20 2007, Canberra, AUS. Journal
Of Gene Medicine 2007: in press.

Glen B Banks, Luke M Judge, Paul Gregorevic, Sheng Li, Caitlin Doremus,
James M Allen, Jeffrey S Chamberlain. Microdystrophin Expression in Mice
Reveals Novel Roles for Full-Length Dystrophin at the Myotendinous Junction.

The 20th Anniversary of the DMD Gene Discovery. Ottowa May 3-5 2007.

Odom GO, Banks GB, Allen JM, Adams, ME, and Chamberlain JS: Functional
analysis of alpha-dystrobrevin-3 in striated muscle with rAAV6 gene
transfer.
The 10th annual meeting of the American Society for Gene Therapy,
May 30-June 3 2007, Seattle, WA. Mol Ther 2007; Volume 15 Supp 1: Abstract
134

Banks GB, Gregorevic P, Allen JM, Finn EE and Chamberlain JS: Functional
capacity of dystrophins N-terminal actin-binding sequences in mdx mice.
The
10th annual meeting of the American Society for Gene Therapy, May 30-June 3
2007, Seattle, WA. Mol Ther 2007; Volume 15 Supp 1: Abstract 127.

Banks GB, Judge LM, Gregorevic P, Li S, Doremus C, Meuse L, Finn EE, Allen
JM, Froehner SC and Chamberlain JS: Microdystrophin expression in dystrophic
mice reveals novel roles for full-length dystrophin at the myotendinous and
neuromuscular junctions.
The 10th annual meeting of the American Society for
Gene Therapy, May 30-June 3 2007, Seattle, WA. Mol Ther 2007; Volume 15 Supp
1: Abstract 409.

Banks GB, Judge LM, Gregorevic P, Li S, Doremus C, Meuse L, Finn EE, Allen
JM, Froehner SC and Chamberlain JS: Development of truncated dystrophins for
gene therapy of DMD.
3rd Seattle Muscular Dystrophy Conference June 13-14
2007.

<< back to Lab Members

 


Home | Research | News | Lab Members | Publications | Benefactors | Employment | Contact Us